Let's not forget that FTT has a solid medical advisory board that includes David Margolis. I assume David and the rest of the board were involved in at least reviewing, if not contributing to, the trial design. Hence I am inclined to think that there is a solid empirical basis for the two week screening period in regard to weeding out self healers.
Let's not forget that FTT has a solid medical advisory board...
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable